- Home
- Companies
- BioSyent Pharma Inc.
- Products
- TIBELLA - Model 2.5mg - Tibolone ...
TIBELLA - Model 2.5mg - Tibolone Tablets
cTIBELLA® (tibolone) is a hormone replacement therapy indicated for short-term treatment of vasomotor symptoms due to estrogen deficiency in postmenopausal women, more than one year after menopause. cTIBELLA® should be prescribed only to women with intact uteri as it includes progestogenic activity1. cTIBELLA® is a 2.5 mg tablet and is available in a 28 day blister.
cTIBELLA (tibolone) is structurally related to the steroidal progestin norethynodrel. Tibolone is converted in the body into three active metabolite which displays tissue-specific effects, which are responsible for estrogenic, progestogenic and androgenic effects. TIBELLA substitutes for the loss of estrogen production in postmenopausal women and alleviates menopausal symptoms.
TIBELLA should be prescribed for the shortest duration consistent with treatment goals1. For additional information, please read the cTIBELLA® Product Monograph.